出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/08/15 11:06:08」(JST)
Gonadotropin-releasing hormone receptor | |
---|---|
Identifiers | |
Symbol | GNRHR |
Alt. symbols | GnRH-R; LRHR; |
Entrez | 2798 |
HUGO | 4421 |
OMIM | 138850 |
RefSeq | NM_000406 |
UniProt | P30968 |
Other data | |
Locus | Chr. 4 q21.2 |
Gonadotropin-releasing hormone (type 2) receptor 2 | |
---|---|
Identifiers | |
Symbol | GNRHR2 |
Entrez | 114814 |
HUGO | 16341 |
RefSeq | NR_002328 |
UniProt | Q96P88 |
Other data | |
Locus | Chr. 1 q12 |
The gonadotropin-releasing hormone receptor (GNRHR), also known as the luteinizing hormone releasing hormone receptor (LHRHR), is a member of the seven-transmembrane, G-protein coupled receptor (GPCR) family. It is expressed on the surface of pituitary gonadotrope cells as well as lymphocytes, breast, ovary, and prostate.
This receptor is a 60 kDa G protein-coupled receptor and resides primarily in the pituitary and is responsible for eliciting the actions of LHRH after its release from the hypothalamus.[1] Upon activation, the LHRHr stimulates tyrosine phosphatase and elicits the release of LH from the pituitary.
Evidence exists showing the presence of LHRH and its receptor in extrapituitary tissues as well as a role in progression of some cancers.[2]
Following binding of Gonadotropin releasing hormone (GNRH), GNRHR associates with G-proteins that activate a phosphatidylinositol (PtdIns)-calcium second messenger system. Activation of GNRHR ultimately causes the release of follicle stimulating hormone (FSH) and luteinizing hormone (LH).
There are two major forms of the GNRHR, each encoded by a separate gene (GNRHR and GNRHR2).[3][4]
Alternative splicing of the GNRHR gene, GNRHR, results in multiple transcript variants encoding different isoforms. More than 18 transcription initiation sites in the 5' region and multiple polyA signals in the 3' region have been identified for GNRHR.
The GNRHR responds to GNRH as well as to synthetic GNRH agonists. Agonists stimulate the receptor, however prolonged exposure leads to a downregulation effect resulting in hypogonadism, an effect that is often medically utilized. GNRH antagonists block the receptor and inhibit gonadotropin release. GNRHRs are further regulated by the presence of sex hormones as well as activin and inhibin.
This section needs attention from an expert in Medicine. Please add a reason or a talk parameter to this template to explain the issue with the section. WikiProject Medicine (or its Portal) may be able to help recruit an expert. (March 2011) |
Defects in the GNRHR are a cause of hypogonadotropic hypogonadism (HH).[5]
Normal puberty begins between ages 8 and 14 in girls and between 9 and 14 in boys. Puberty, however, for some children can come much sooner or much later or in many cases never occurs and thereby contributes to the estimated 35-70 million infertile couples worldwide. Among children, the abnormally early or late onset of puberty exerts intense emotional and social stress that too often goes untreated.
The timely onset of puberty is regulated by many factors and one factor that is often referred to as the master regulator of puberty and reproduction is the gonadotropin-releasing hormone (GnRH). GnRH is produced in the hypothalamus but gets secreted and acts upon receptors (GnRH-R) on the anterior pituitary to exert its effects on reproductive maturation.
Understanding how GnRH-R functions has been key to developing clinical strategies to treat reproductive-related disorders.[6][7][8]
|
|
|
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
リンク元 | 「性腺刺激ホルモン放出ホルモン受容体」「LHRH受容体」「GnRH受容体」「GnRHレセプター」 |
関連記事 | 「GnRH」 |